Foghorn Therapeutics Inc. (FHTX) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$8.61M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$21.34M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$23.08M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$17.6M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$8.61M | (m) | (m) | (m) | -53.54% | $50.00K* | -$17.84M* | (m) | $18.52M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$21.34M | (m) | (m) | (m) | -653.05% | $0.00 | -$25.27M | (m) | $18.26M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$23.08M | (m) | (m) | (m) | -249.55% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$17.6M | (m) | (m) | (m) | -215.88% | $0.00* | -$18.86M* | (m) | $20.00M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$20.2M | (m) | (m) | (m) | -267.26% | $22.00K* | -$21.00M* | (m) | $21.79M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$22.09M | (m) | (m) | (m) | -371.07% | $28.00K | -$23.97M | (m) | $21.63M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$23.24M | (m) | (m) | (m) | -813.87% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$23.15M | (m) | (m) | (m) | -296.52% | $309.00K* | -$21.00M* | (m) | $24.69M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | -$25.83M | (m) | (m) | (m) | -375.03% | $17.00K* | -$25.54M* | (m) | $23.80M | (m) | $0.00 |
|---|
| 2024-03-31 | Reported | -$27.36M | (m) | (m) | (m) | -541.76% | $101.00K | -$29.34M | (m) | $25.53M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$24.61M | (m) | (m) | (m) | -426.52% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$16.18M | (m) | (m) | (m) | -92.58% | $82.00K* | -$27.21M* | (m) | $26.25M | (m) | $738.00K |
|---|
| 2023-06-30 | Reported | -$31.25M | (m) | (m) | (m) | -558.14% | $469.00K* | -$32.17M* | (m) | $29.25M | (m) | $942.00K |
|---|
| 2023-03-31 | Reported | -$32.46M | (m) | (m) | (m) | -611.38% | $636.00K | -$31.18M | (m) | $29.98M | (m) | $560.00K |
|---|
| 2022-12-31 | Reported | -$31.04M | (m) | (m) | (m) | -741.83% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$27.36M | (m) | (m) | (m) | -412.41% | $330.00K* | -$19.99M* | (m) | $26.93M | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | -$28.39M | (m) | (m) | (m) | -632.25% | $364.00K* | -$29.01M* | (m) | $25.97M | (m) | $0.00 |
|---|
| 2022-03-31 | Reported | -$26.99M | (m) | (m) | (m) | -688.60% | $247.00K | $271.53M | (m) | $24.51M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$27.27M | (m) | (m) | (m) | -3824.96% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$25.46M | (m) | (m) | (m) | -62100.00% | $230.00K* | -$20.50M* | (m) | $20.49M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$22.46M | (m) | (m) | (m) | -8050.54% | $1.21M* | -$18.48M* | (m) | $18.64M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$22.36M | (m) | (m) | (m) | -7817.48% | $1.79M | -$23.15M | (m) | $18.73M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$20.22M | (m) | (m) | (m) | -8054.18% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$18.19M | (m) | (m) | (m) | -10161.45% | $5.42M* | $2.73M* | (m) | $16.11M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$15.34M | (m) | (m) | (m) | (m) | $2.25M* | -$12.60M* | (m) | $13.63M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$13.47M | (m) | (m) | (m) | (m) | $1.02M | -$10.76M | (m) | $11.50M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$14.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$13.10M | (m) | (m) | (m) | (m) | (m) | (m) | $11.29M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$83.06M | (m) | (m) | (m) | -268.71% | $50.00K | -$86.10M | (m) | $85.47M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$99.56M | (m) | (m) | (m) | -440.51% | $906.00K | -$100.41M | (m) | $94.53M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$104.46M | (m) | (m) | (m) | -305.83% | $1.22M | -$118.11M | (m) | $109.69M | (m) | $4.23M |
|---|
| 2022-12-31 | Reported | -$113.82M | (m) | (m) | (m) | -591.93% | $1.21M | $193.61M | (m) | $105.62M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$97.51M | (m) | (m) | (m) | -7392.49% | $3.31M | -$50.25M | (m) | $80.33M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$67.2M | (m) | (m) | (m) | -15628.84% | $16.18M | -$31.29M | (m) | $57.72M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$50.39M | (m) | (m) | (m) | (m) | $968.00K | -$46.34M | (m) | $44.36M | (m) | $0.00 |
|---|